HASSANEIN WALEED H (President & CEO) received a stock award from TRANSMEDICS GROUP, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/26/2025ACC: 0000950170-25-028069
DirectorOfficer· President & CEO
Since May 2019
+149.97K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
149.97K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+59.78K
Price / share
—
Trade value
—
% of position
97.0%
2/25/2025
61.64K→121.42K
Total
Net shares
+59.78K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/25/2025 | A · Award | +59.78K | — | — | 97.0% | 61.64K | 121.42K |
| Total | +59.78K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
90.19K shares
Shares
+90.19K
Strike price
73
Held after
90.19K
Exercisable
—
2/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock90.19K shares | 2/25/2025 | A · Award | +90.19K | 73 | — | 90.19K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned469.36K
Total
469.36K indirect469.36K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 469.36K | Indirect |
| Total | 469.36K | 469.36K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported